E-DRUG: Technical Briefing Seminar:QA and Safety, Blood Products, Biologicals
---------------------------------------------------------------
[To respond DO NOT CLICK REPLY. application details are available at :
http://www.who.int/medicines/areas/quality_safety/qsm_tbs/en/index.html
or contact Ms Ana Garcia Miguel <garciamiguela@who.int> ]
Dear Colleagues,
The Quality Assurance and Safety: Medicines team (in the Department of
Medicines Policy and Standards), WHO is organizing its second Technical
Briefing Seminar by the title:
Quality Assurance and Safety of Medicines:
Promoting Global Collaboration
Venue: WHO Headquarters, Geneva, Salle M 505
Dates: 22-26 September 2008
The objective of the Seminar is to advance collaboration between WHO and
other stakeholders from governmental and non-governmental organizations
engaged in promoting the quality and safety of medicines in the global
community.
The programme for this year will be based on that of last year, to
increase awareness and knowledge of quality assurance and safety of
medicines, blood products and related biologicals with a special focus
on WHO standard-setting processes. Presentations, briefing and
discussion topics will include :
* WHO development of guidelines, pharmacopoeial monographs and
information resources
* collaborative approaches underpinning classification systems
(International nonproprietary names, Anatomical Therapeutic Chemical
(ATC) Classification
* quality assurance of medicines, blood products and related
biologicals
* WHO prequalification project activities
* WHO global pharmacovigilance programme
* WHO input to international control of narcotic and psychotropic
substances
Audience
The technical briefing will be of interest to technical officers, WHO
Representatives, regional advisers and country office staff of WHO and
other UN agencies, national and regional drug regulators, and government
and non-government officials working in related areas.
Specific Objectives
By attending this briefing, participants will understand:
1. The methodologies, technical tools and algorithms used to develop WHO
guidelines;
2. The roles and functions of the Quality Assurance and Safety:
Medicines (QSM), and Quality Assurance and Safety: Blood Products and
Related Biologicals (QSD) teams and how they collaborate with other WHO
departments and Member States in promoting global standards of quality
and safety of human medicines;
3. The activities of the WHO Regional Offices and WHO Collaborating
Centres;
4. How QSM / QSD activities help meet the goals and strategic objectives
of the WHO Essential Medicines Programme.
Seminar design
This will be in the form of an interactive seminar with presentations on
individual topics followed by working group exercises on specific tools
and techniques (e.g. databases, adverse drug reaction reporting forms,
case studies etc). Technical officers from WHO and relevant
Collaborating Centres, senior consultants and WHO experts will lead and
facilitate the programme.
The programme from last year as well as application details for this
year are available at :
http://www.who.int/medicines/areas/quality_safety/qsm_tbs/en/index.html
We will soon post this year's programme at the above link.
Attendance is limited to 35 places. Participation is free of charge.
However, each participant is responsible for own travel and
accommodation costs.
The closing date for submission of applications is 10 August 2008.
Completed application forms should be sent to:
Ms Ana Garcia-Miguel
Quality Assurance and Safety: Medicines
World Health Organization
Geneva 1211
Switzerland
Fax: 00 41 22 791 4730
E-mail: garciamiguela@who.int
With best regards,
Shanthi Pal
Dr Shanthi Pal
Technical Officer
Quality Assurance and Safety: Medicines
WHO
1211 Geneva 27
Switzerland
Tel: 41-22-7911318
Fax: 41-22-7914730